EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSUAMG00000008699
Gene Symbol: HDAC11
2 Cross references
197 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSUAMG00000000102
Gene Symbol: HDAC2
2 Cross references
202 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSUAMG00000028355
Gene Symbol: HDAC3
2 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSUAMG00000010633
Gene Symbol: HDAC4
2 Cross references
263 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSUAMG00000009148
Gene Symbol: HDAC6
2 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSUAMG00000026809
Gene Symbol: HDAC7
2 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSUAMG00000027942
Gene Symbol: HDAC8
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSUAMG00000018447
Gene Symbol: HDAC9
2 Cross references
234 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSUAMG00000016534
Gene Symbol: HSD11B1
2 Cross references
248 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSUAMG00000019735
Gene Symbol: HCN4
2 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSUAMG00000004880
Gene Symbol: HCRTR1
2 Cross references
96 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSUAMG00000011241
Gene Symbol: IDO1
2 Cross references
98 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).